Estimate of disability-adjusted life-years gained by Helicobacter pylori screening and treatment in different populations*
| Population | Mean DALYs gained | 95% CI |
| Global | 8 814 649 | 5 742 067 to 11 887 230 |
| Men | 5 650 560 | 3 672 479 to 7 628 640 |
| Women | 3 165 033 | 2 049 244 to 4 280 822 |
| East Asia | 3 754 826 | 2 459 850 to 5 049 802 |
| South Asia | 1 211 289 | 786 289 to 1 636 290 |
| North Africa and the Middle East | 395 681 | 254 071 to 537 291 |
| Eastern Europe | 468 015 | 304 225 to 631 804 |
| Western Europe | 470 721 | 303 803 to 637 640 |
| High income North America | 192 702 | 124 729 to 260 675 |
| Central Latin America | 224 425 | 144 883 to 303 966 |
| Southern Latin America | 93 391 | 59 901 to 126 881 |
| Australasia | 18 286 | 11 638 to 24 933 |
*These analyses relate to all of the impact of H. pylori testing and eradication in the population described, and the DALYs gained is what would be achieved hypothetically over the lifetime of the population being screened at a given time point.
DALYs, disability-adjusted life-years; H. pylori, Helicobacter pylori.